Thymic Self-Antigen Expression for the Design of a Negative/Tolerogenic Self-Vaccine against Type 1 Diabetes
Before being able to react against infectious non-self-antigens, the immune system has to be educated in the recognition and tolerance of neuroendocrine proteins, and this critical process essentially takes place in the thymus. The development of the autoimmune diabetogenic response results from a t...
Saved in:
| Main Authors: | Aziz Alami Chentoufi, Vincent Geenen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2011-01-01
|
| Series: | Clinical and Developmental Immunology |
| Online Access: | http://dx.doi.org/10.1155/2011/349368 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Type 1 Diabetes Immunological Tolerance and Immunotherapy
by: Aziz Alami Chentoufi, et al.
Published: (2011-01-01) -
A comprehensive overview of tolerogenic vaccine adjuvants and their modes of action
by: Sabine Arve-Butler, et al.
Published: (2024-12-01) -
Role of USP7 in the regulation of tolerogenic dendritic cell function in type 1 diabetes
by: Farhan Ullah Khan, et al.
Published: (2025-04-01) -
Intestinal CD4−CD8αβ−TCRαβ+ T cells function as tolerogenic antigen presenting cells in mice
by: Yasuhiro Nemoto, et al.
Published: (2025-08-01) -
Metabolism Is Central to Tolerogenic Dendritic Cell Function
by: Wen Jing Sim, et al.
Published: (2016-01-01)